Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 5:39 PM
Ignite Modification Date:
2025-12-25 @ 3:09 PM
NCT ID:
NCT03045068
Group ID:
EG001
Title:
Control Group
Description:
Platelet Transfusion Management
1. Pre-Termination of CPB- No intervention
2. Post CPB- Platelet transfusion 20ml/kg via a central venous line is continued at a rate of 100 ml/hour till completion.
Platelet Transfusion: Post CPB- Platelet transfusion 20ml/kg via a central venous line is continued at a rate of 100 ml/hour till completion.
1. Initial transfusion to occur proximal to the hemofilter on the MUF circuit for as long as MUF lasts
2. Subsequent platelet transfusion continued till completion via central venous access to the patient
FFP and Cryoprecipitate: 1. 1 unit of cryoprecipitate administered during MUF and or after MUF as needed 2. FFP transfusion 10ml/kg during MUF and or after MUF as needed
PRBC and cell saver Transfusion: 1. Transfuse for target Hematocrit \> 40 in neonates with SV physiology; Transfuse for Hematocrit\> 33 for 2-Ventricle physiology
Factor Concentrate (Bebulin): 1. Based on clinical bleeding and achievement of hemostasis
Deaths Number Affected:
0
Deaths Number At Risk:
None
Serious Number Affected:
4
Serious Number At Risk:
21
Other Number Affected:
6
Other Number At Risk:
21
Study:
NCT03045068
Results Section:
NCT03045068
Adverse Events Module:
NCT03045068